Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Katoh, Makoto ^a   Egashira, Kensuke ^b   Kataoka, Chu ^b   Usui, Makoto ^b   Koyanagi, Masamichi ^b   Kitamoto, Shiro ^b   Ohmachi, Yasushi ^a   Takeshita, Akira ^b   Narita, Hiroshi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin; Apoptosis; Nitric oxide; Remodeling

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRINKING WATER; IMIDAPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OLMESARTAN;

ANIMAL MODEL; APOPTOSIS; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; INFLAMMATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0035026286     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.5.h2306     Document Type: Article

References (38)

1. Alexander RW and Griendling KK. Signal transduction in vascular smooth muscle. J Hypertens Suppl 14: S51-S54, 1996.
2. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, and Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl Acad Sci USA 94: 10057-10062, 1997.
3. DeBlois D, Tea BS, Than VD, Tremblay J, and Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 29: 340-349, 1997.
4. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 39: 287-324, 1997.
5. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, and Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665, 1997.
6. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, and Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88: 77-81, 1993.
7. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, and Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 91: 29-37, 1993.
8. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl Memorial Lecture. Hypertension 16: 363-370, 1990.
9. Farhy RD, Carretero OA, Ho KL, and Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 72: 1202-1210, 1993.
10. Franke TF, Kaplan DR, and Cantley LC. PI3K: downstream AKT ion blocks apoptosis. Cell 88: 435-437, 1997.
11. Griendling KK and Alexander RW. Endothelial control of the cardiovascular system: recent advances. FASEB J 10: 283-292, 1996.
12. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, and Egido J. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95: 1532-1541, 1997.
13. Holm AM, Andersen CB, Haunso S, and Hansen PR. ACE-inhibition promotes apoptosis after balloon injury of rat carotid arteries. Cardiovasc Res 45: 777-782, 2000.
14. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, and Fishman MC, Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
15. Katoh M, Egashira K, Mitsui T, Chishima S, Takeshita A, and Narita H. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. J Mol Cell Cardiol 32: 73-83, 2000.
16. Katoh M, Egashira K, Usui M, Ichiki T, Tomita H, Shimokawa H, Rakugi H, and Takeshita A. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats. Circ Res 83: 743-751, 1998.
17. Kauffmann ZA, Rodriguez VP, Ulrich E, Gilbert C, Coffer P, Downward J, and Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548, 1997.
18. 1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. Hypertension 35: 86-90, 2000.
19. Loscalzo J and Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38: 87-104, 1995.
20. G-nitro L-arginine methyl ester due to converting enzyme inhibition. J Cardiovasc Pharmacol 28: 142-148, 1996.
21. Mizuno M, Sada T, Ikeda M, Fukuda N, Miyamoto M, Yanagisawa M, and Koike H. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur J Pharmacol 285: 181-188, 1995.
22. Moreau P, Takase H, Kung CF, Shaw S, and Luscher TF. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. Hypertension 29: 763-769, 1997.
23. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, and Huang PL. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 101: 1225-1232, 1998.
24. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, and Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension 26: 957-962, 1995.
25. Pollman MJ, Yamada T, Horiuchi M, and Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 79: 748-756, 1996.
26. Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 105: 32S-39S, 1998.
27. Sharifi AM and Schiffrin EL. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism. J Hypertens 15: 1441-1448, 1997.
28. Sharifi AM and Schiffrin EL. Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin-converting enzyme inhibitor and a calcium channel antagonist. Am J Hypertens 11: 1108-1116, 1998.
29. Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y, and Yokoyama M. Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 276: H1927-H1934, 1999.
30. Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, and Takeshita A. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension 30: 1621-1627, 1997.
31. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, and Takeshita A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99: 278-287, 1997.
32. Takemura G, Ohno M, Hayakawa Y, Misao J, Kanoh M, Ohno A, Uno Y, Minatoguchi S, Fujiwara T, and Fujiwara H. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82: 1130-1138, 1998.
33. Tomita H, Egashira K, Kubo-Inoue M, Usui M, Koyanagi M, Shimokawa H, Takeya M, Yoshimura T, and Takeshita A. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler Thromb Vasc Biol 18: 1456-1464, 1998.
34. Tomita H, Egashira K, Ohara Y, Takemoto M, Koyanagi M, Katoh M, Yamamoto H, Tamaki K, Shimokawa H, and Takeshita A. Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 32: 273-279, 1998.
35. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fuji Y, Walsh K, and Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274: 22699-22704, 1999.
36. Usui M, Egashira K, Tomita H, Koyanagi M, Katoh M, Shimokawa H, Takeya M, Yoshimura T, Matsushima K, and Takeshita A. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation 101: 305-310, 2000.
37. Wang B, Ho HV, Lin PS, Schwarzacher SP, Pollman MJ, Gibbons GH, Tsao PS, and Cooke JP. Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation 99: 1236-1241, 1999.
38. Zong WX, Edelstein LC, Chen C, Bash J, and Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNF-α-induced apoptosis. Genes Dev 13: 382-387, 1999.